Zinner Named CEO of Miami Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MICHAEL ZINNER was named CEO and executive medical director of Miami Cancer Institute at Baptist Health South Florida.

Zinner served as clinical director at Dana-Farber/Brigham and Women’s Cancer Center, and surgeon-in-chief at the Brigham and Women’s Hospital. He is also the Moseley Professor of Surgery at Harvard Medical School and founder of Harvard’s Center for Surgery and Public Health. Zinner is also co-founder and co-director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute.

From 2008 to 2010, Zinner was the chairman of the Board of Governors of the American College of Surgeons, and is now vice chair of the Board of Regents. Additionally, he is chairman of the organization’s Health Policy and Advocacy Committee.

A Miami native, Dr. Zinner received his M.D. degree from the University of Florida and did his surgical residency at Johns Hopkins Hospital.

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login